TJ DaRenTang USD
T142.7900.00% ( 0.000 )
TJ DaRenTang USD (T14)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese me...
- Open
- 2.810
- High
- 2.840
- Low
- 2.780
- Prev. Close
- 2.790
- Volume
- 255.80K
- Turnover
- 716.62K
- Avg Price
- 2.801
- Bid/Ask Ratio
- 22.54%
- Amplitude
- 2.15%
- 52wk High
- 3.406
- Volume Ratio
- 1.45
- Turnover Ratio
- 0.06%
TJ DaRenTang USD Analyst Rating
View MoreForecast & Rating
Mar 9, 2023Price forecast
S$1.25-55.22%
Forecast & Rating-
0analysts
News
- Zhitong · Aug 14, 2025 at 03:31 AM
TJ DaRenTang announced its semi-annual performance, with a net profit attributable to the parent company of 1.928 billion yuan, a year-on-year increase of 193.08%
- Zhitong · Jul 18, 2025 at 09:17 AM
TJ DaRenTang: Tongmai Yangxin Pills strongly recommended in the Traditional Chinese Medicine Diagnosis and Treatment Guidelines for Coronary Microvascular Disease
- Zhitong · Jul 14, 2025 at 03:30 AM
TJ DaRenTang: Expected net profit in the first half of 2025 to increase by 180%-204% year-on-year
- Zhitong · Apr 29, 2025 at 09:21 AM
TJ DaRenTang announced its first-quarter performance, with a net profit attributable to the parent company of 374 million yuan, a year-on-year decrease of 3.38%
- Zhitong · Apr 15, 2025 at 04:34 AM
TJ DaRenTang plans to sell 12% of its shares in Tianjin Shike for 1.623 billion yuan to increase cash inflow
- Zhitong · Mar 30, 2025 at 04:21 AM
DRTG released its 2024 annual performance, with a net profit attributable to the parent company of 2.229 billion yuan, a year-on-year increase of 125.94%
